| Cohance Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543064 |
NSE Symbol : COHANCE |
P/E(TTM) : 89.21 |
|
ISIN Demat : INE03QK01018 |
Div & Yield% : 0.00 |
EPS(TTM) : 5.00 |
|
Book Value(₹) : 117.10 |
Market Cap(₹Cr) : 17,065.75 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,030.50 | 2,504.43 | 1,051.35 | 1,330.08 | 1,320.22 |
| Other Income | 44.73 | 64.84 | 56.61 | 44.55 | 187.79 |
| Stock Adjustments | 38.58 | -110.32 | -49.16 | 20.94 | 60.35 |
| Total Income | 2,113.81 | 2,458.95 | 1,058.80 | 1,395.57 | 1,568.36 |
| EXPENDITURE : | |||||
| Raw Materials | 691.27 | 699.91 | 265.88 | 421.36 | 459.46 |
| Power and Fuel Cost | 109.60 | 102.39 | 48.30 | 71.35 | 59.55 |
| Other Manufacturing Expenses | 213.69 | 195.14 | 88.31 | 101.96 | 115.25 |
| Selling and Administration Expenses | 180.05 | 159.61 | 37.51 | 43.57 | 52.38 |
| Miscellaneous Expenses | 69.10 | 72.08 | 21.10 | 13.50 | 11.17 |
| Employee Benefit Expenses | 380.43 | 396.55 | 135.23 | 108.58 | 100.48 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 469.67 | 833.27 | 462.47 | 635.24 | 770.08 |
| Interest | 22.46 | 36.70 | 7.45 | 12.75 | 8.53 |
| Gross Profit | 447.21 | 796.57 | 455.02 | 622.49 | 761.55 |
| Depreciation | 133.58 | 146.51 | 54.60 | 43.10 | 39.10 |
| Profit Before Tax | 313.63 | 650.06 | 400.42 | 579.39 | 722.45 |
| Current Tax | 78.10 | 171.31 | 97.36 | 142.45 | 157.63 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 6.82 | -12.43 | 6.59 | 4.34 | 6.72 |
| Reported Net Profit | 228.71 | 491.18 | 296.47 | 432.60 | 558.10 |
| Extraordinary Items | -20.67 | -11.72 | -0.05 | 10.55 | 14.53 |
| Adjusted Net Profit | 249.38 | 502.90 | 296.52 | 422.05 | 543.57 |
| Adjustment below Net Profit | 1.53 | 0.33 | -0.32 | -0.26 | -0.76 |
| Profit/Loss Balance carried down | 2,739.59 | 2,248.08 | 1,470.91 | 1,276.39 | 835.88 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 218.65 | 116.83 |
| P & L Balance carried down | 2,969.83 | 2,739.59 | 1,767.06 | 1,490.07 | 1,276.39 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 600.00 | 500.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 6.00 | 5.00 |
| Earnings Per Share-Unit Curr | 5.98 | 19.29 | 11.64 | 16.99 | 21.92 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 117.10 | 166.88 | 79.67 | 68.72 | 59.74 |
| Book Value(Adj)-Unit Curr | 117.10 | 166.88 | 79.67 | 68.72 | 59.74 |
